BAMS
TBPH icon

Bellevue Asset Management (Switzerland)’s Theravance Biopharma TBPH Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$187K Hold
11,428
– – 0.03% 124
2015
Q3 		$126K Hold
11,428
– – 0.02% 129
2015
Q2 		$149K Sell
11,428
-16,463
-59% -$255K 0.02% 136
2015
Q1 		$484K Buy
+27,891
New +$511K 0.07% 133

Other funds holding TBPH

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s TBPH Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) held its Theravance Biopharma (TBPH) position steady in Q4 2015 at 11,428 shares worth $187K. The position accounts for 0.03% of the portfolio, ranked #124.

Bellevue Asset Management (Switzerland) first reported a position in TBPH in Q1 2015 and has held it in 4 quarters since. The position peaked at $484K in Q1 2015. 83 funds tracked by Wall St. Rank hold TBPH as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 11,428 shares of Theravance Biopharma worth $187K as of Q4 2015.
  • Bellevue Asset Management (Switzerland) left its Theravance Biopharma share count unchanged in Q4 2015.
  • Theravance Biopharma made up 0.03% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #124 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Theravance Biopharma in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s Theravance Biopharma position peaked at $484K in Q1 2015.
  • 83 funds tracked by Wall St. Rank held Theravance Biopharma as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.